The State of SDoH Impact Evaluation Funding in 2024

Defining Research and Evaluation for SDoH Interventions in Diabetes Care

The Banking Institution's funding opportunity for pilot and feasibility trials focuses on testing pragmatic interventions that address adverse social determinants of health (SDoH) for individuals living with type 1 diabetes. Research and evaluation play a crucial role in this context, as they enable the assessment of intervention effectiveness, identification of best practices, and inform future healthcare strategies. To be eligible for this grant, applicants must demonstrate a clear understanding of research and evaluation methodologies tailored to SDoH interventions.

Scope and Concrete Use Cases for Research and Evaluation

Applicants should focus on designing and implementing rigorous research studies that assess the impact of SDoH screening and referral interventions on health outcomes for type 1 diabetes patients. This includes evaluating the effectiveness of different screening tools, referral processes, and resource service linkages. Concrete use cases include assessing the feasibility of integrating SDoH screening into routine clinical practice, examining the effect of SDoH interventions on patient engagement and health outcomes, and comparing different models of resource service linkage. Researchers should also consider the specific needs of diverse patient populations, such as those in New York City and North Carolina, where the prevalence of type 1 diabetes and SDoH may vary.

The National Science Foundation's (NSF) guidelines for Small Business Innovation Research (SBIR) grants provide a relevant framework for research and evaluation design. Applicants should be aware of the NSF's emphasis on innovation, rigorous research methods, and potential for commercialization. In the context of SDoH interventions, this might involve developing novel screening tools or evaluating the effectiveness of existing ones. The Christopher Reeve Foundation's approach to grant-making for research on paralysis and other conditions also highlights the importance of rigorous evaluation and outcome measurement.

Trends and Priorities in SDoH Research and Evaluation

The Banking Institution's funding priority reflects a growing recognition of the impact of SDoH on health outcomes, particularly for chronic conditions like type 1 diabetes. Recent policy shifts, such as the National Institute of Health's (NIH) increased focus on SDoH research, underscore the importance of this area. Applicants should demonstrate an understanding of current market trends, including the development of new SDoH screening tools and the integration of social services into healthcare settings. The NSF's SBIR funding priorities also highlight the importance of innovation and entrepreneurship in addressing healthcare challenges.

To be competitive, applicants must prioritize capacity building for research and evaluation, including staff training and infrastructure development. This may involve collaboration with healthcare providers, social service organizations, and research institutions to leverage expertise and resources. Applicants should be aware of the specific requirements for SBIR grants, including the need for a clear commercialization plan.

Operationalizing Research and Evaluation for SDoH Interventions

Delivering effective research and evaluation for SDoH interventions poses several challenges. One key constraint is ensuring the accuracy and reliability of SDoH screening tools, which may require significant data collection and validation efforts. Applicants should also anticipate challenges related to participant recruitment and retention, particularly in vulnerable populations. The NIH's guidance on research involving human subjects provides a relevant framework for addressing these challenges.

In terms of workflow and staffing, research and evaluation teams will require expertise in study design, data analysis, and project management. Applicants should plan for adequate resources to support participant recruitment, data collection, and intervention delivery. The Banking Institution's grant amount of $350,000 will need to be carefully allocated to cover these costs.

One concrete regulation that applies to this sector is the requirement for Institutional Review Board (IRB) approval for research involving human subjects. Applicants must demonstrate compliance with relevant regulations and guidelines, such as those related to data protection and participant confidentiality. The NSF's guidelines for SBIR grants also require compliance with specific regulations and standards.

A verifiable delivery challenge unique to this sector is the need to balance research rigor with the practical demands of clinical practice. Applicants must navigate the tension between controlling for variables in a research setting and ensuring that interventions are feasible and effective in real-world healthcare environments.

Measuring Success in SDoH Research and Evaluation

The Banking Institution's funding opportunity requires applicants to specify clear outcomes and KPIs for their research and evaluation projects. Relevant metrics may include measures of SDoH screening uptake, referral rates, and patient engagement, as well as health outcomes such as HbA1c levels and hospitalization rates. Applicants should also plan for ongoing reporting and evaluation, including regular progress updates and a final project report.

To be eligible for funding, applicants must demonstrate a clear understanding of the research and evaluation requirements for SDoH interventions. This includes a well-designed study protocol, a robust data analysis plan, and a clear plan for disseminating findings.

Q: How do I ensure that my research and evaluation design is eligible for this funding opportunity? A: To be eligible, your design should focus on testing pragmatic interventions that address adverse SDoH for individuals living with type 1 diabetes, and demonstrate a clear understanding of relevant research and evaluation methodologies, such as those outlined in NSF's SBIR guidelines.

Q: What are the key challenges in operationalizing research and evaluation for SDoH interventions, and how can I address them? A: Key challenges include ensuring the accuracy of SDoH screening tools and balancing research rigor with clinical practice demands. To address these challenges, consider collaborating with healthcare providers and research institutions to leverage expertise and resources, and plan for adequate staffing and resources to support participant recruitment and data collection.

Q: How will I be required to measure and report on the success of my research and evaluation project? A: You will be required to specify clear outcomes and KPIs, such as measures of SDoH screening uptake and health outcomes, and provide regular progress updates and a final project report. The Banking Institution's funding opportunity emphasizes the importance of rigorous evaluation and outcome measurement, consistent with the NIH's guidance on research involving human subjects.